The Cac 40 is preparing to rebound at the opening on Tuesday, in the wake of US futures contracts. The atmosphere remains very tense, while the Omicron variant is becoming dominant in most of the large infected countries. With a risk for growth.


After a drop of nearly 3% in the space of three sessions, including a drop of 1.2% yesterday, it is logical that the Dow Jones has some hints of a rebound on Tuesday, as the index futures contracts suggest.

Very mechanically, the Paris Bourse will benefit this morning, the Cac 40 is expected to rise by just over 1% at half an hour from the first exchanges. Enough to erase the loss of 0.82% of the day before, but not the drop of 1.12% of Friday.

Omicron becomes dominant

A rebound that will remain fragile anyway, as the Omicron threat is present in everyone’s mind. According to data from the Centers for Disease Control and Prevention (CDC), the Covid variant accounted for 73% of new cases observed as of December 18, compared to 26.6% for the Delta. A week earlier, the latter constituted 87% of new cases, compared to 12.6% for Omicron (less than 3% as of December 11).

In New York City, 7,200 cases are currently seen per day (weekly average), more than twice the 3,200 the week before. Nationwide, 130,000 cases were detected in one week, according to data compiled by Johns Hopkins University, up 7% in the past two weeks. If the symptoms of this variant appear milder, hospitals may quickly become congested, which is moreover during this holiday season.

The deadlocked Biden plan

The downward movement of the markets ” reflects growing uncertainty as to whether Omicron’s push will lead to further far-reaching restrictions, with its consequences for the economy, the unexpected suspension of additional fiscal stimulus from President Biden’s Build Back Better plan and the breaking , by the S&P 500 Index, of its 50-day moving average “, Explained yesterday Jim Paulsen, chief investment strategist at Leuthold Group, in full decline of the major American indices.

If, in Europe, we are particularly worried about the package of measures restricting the movement of the population in most of the large countries of the western part, in the United States, the uncertainty also relates to the difficulties of President Joe Biden to pass his plan of 1.750 billion dollars, “Build Back Better”, already rejected by the democratic senator Joe Manchin. ” With increasing volatility, we might see Santa Claus take over the reins of Manchin for the next two sessions. », Reassures this morning Ipek Ozkardeskaya, senior analyst at Swissquote.

The program of the day is, like the day before, very light, no leading statistics appearing in the program.

Takeover for Sanofi, sale to Bolloré

To companies, no publication, of course, but Sanofi continues shopping. The laboratory announces the acquisition of the American Amunix Pharmaceuticals, specializing in immuno-oncology for an amount of at least $ 1 billion.

Bollore, on the contrary, is negotiating the sale of Bolloré Africa Logistics, which brings together the group’s transport and logistics activities in Africa, to the maritime carrier MSC for 5.7 billion euros.

In terms of analysts, Citi is revising upwards its price targets on BNP Paribas and Euronext.




Source link -90